REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 220.00
Ask: 300.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 260.00
High: 260.00
Low: 260.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results for the Six Months 30 June 20

7 Sep 2020 07:00

RNS Number : 1517Y
Spectra Systems Corporation
07 September 2020
 

 

Spectra Systems Corporation

Interim Results for the Six Months Ended 30 June 2020

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Spectra Systems Corporation (the "Company"), a leading provider of advanced technology solutions for banknote and product authentication, is pleased to announce its interim results for the six months ended 30 June 2020.

 

 

Financial highlights:

 

· Revenue of $6,519k (2019: $6,402k)

 

· Adjusted EBITDA1 of $2,442k (2019: $2,461k)

 

· Adjusted earnings2 per share of US $4.6 cents (2019: US $4.8 cents)

 

· Cash generated from operations of $2,283k (2019: $1,993k)

 

· Special annual 2019 dividend up 28.5% to US$0.09 per share ($4,123k in aggregate) paid in June 2020

 

· Strong, debt-free balance sheet, with cash3 of $10,906k (2019: $11,142k) at 30 June

 

· $40,000 donated to US and UK charities supporting the fight against hunger during Covid-19

 

 

1 Before stock compensation expense

2 Before amortization and stock compensation expense

3 Does not include $1,344k (2019: $1,099k) of restricted cash and investments

 

 

Operational highlights:

· Execution of a new contract with a central bank to enhance existing authentication sensors to detect a unique type of counterfeit notes

 

· Continued research funding for future sensor technology development for a central bank

 

· Strong sales of optical materials for K-cups

 

· Launch of a new phosphor which outperforms existing leading materials and can be sold at a significant discount to incumbents

 

· Successful production of fully printed, machine-readable polymer banknotes with covert taggants

 

· Ongoing Covid-19 studies on Aeris banknote decontamination efficacy at a major University with Bio-Safety Level IV facilities

 

· Four lottery contract renewals for the secure transactions group

 

 

Commenting on the results, Nabil Lawandy, Chief Executive Officer, said:

 

"The Company's first half revenues and earnings are fully in line with last year and the Board's expectations for H1 and our cash generated by operations is up by 14% relative to H1 2019. We have obtained new business from a long standing central bank customer which supports our position as the technology leaders for difficult technological requirements. Our K-Cup business continues to grow and we have introduced a new phosphor into the optical materials market which outperforms the best incumbent product on both brightness as well as price. Our machine readable polymer technology has been successfully incorporated into fully finished house banknotes which will serve as standards for the full rollout of the product to central banks. Furthermore, discussion with central banks during H1 have reinforced our belief that worldwide demand for banknotes will be significantly higher this year than last year and that this will positively impact our earnings in H2 of this year."

"Finally, our secure transactions group continues to win renewal contracts and our Aeris banknote cleaning system has attracted unprecedented attention from potential central bank and casino customers during the first half of 2020. We are optimistic that the Covid 19 fueled interest in Aeris will result in a sale of a unit in 2021."

The Board therefore believes that the Company is on track to achieve record earnings for the full year and expects both revenue and earnings to significantly exceed market expectation for the full year.

 

Enquiries:

 

Spectra Systems Corporation

 

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0) 401 274 4700

 

WH Ireland Limited

 

 

Chris Fielding, Managing Director Corporate Finance

Tel: +44 (0) 20 7220 1650

 

 

Chief Executive Officer's statement

 

Introduction

Having achieved a number of key commercial milestones, as described in the Review of Operations below, Spectra Systems is on track to deliver an excellent performance for the full 2020 financial year and expects to significantly exceed market expectations for 2020, in spite of the Covid-19 pandemic.

Revenue was up 2% at $6,519k (2019: $6,402k) during the first half of the year. Revenue this year will be biased towards the second half of 2020 with significant positive earnings anticipated throughout H2. Increased revenues are expected from pre-production development contracts as well as larger demand for our materials to meet increased banknote demands of one of our existing central bank customers.

 

Adjusted EBITDA (before stock compensation expense) for the half year was flat at $2,442k compared to the prior year of $2,461k.

 

Having generated cash from operations of $2,283k (2019: $1,993k), cash at the period end amounted to $10,906k (2019: $11,142k), excluding $1,344k of restricted cash and investments (2019: $1,099k). This is notwithstanding $4,123k paid to shareholders during June in the form of the Company's special dividend of $0.09 per share.

 

Based on the expected revenue and earnings for the second half of the year, as well as the lowered cash requirements, the Company anticipates a similar end of the year dividend relative to the 2018 dividend paid in June 2019.

 

 

Review of Operations

 

 

Physical and Software Authentication Business

 

The Authentication Systems business, which includes security phosphor materials, generated revenue of $5,826k (2019: $5,722k) and Adjusted EBITDA of $2,286k (2019: $2,280k).

 

Authentication Systems revenues were primarily in the form of direct sales of materials and equipment to an existing central bank customer and royalty and licence payments by our licensee. Revenues in the first half of the year are in line with H1 2019.

 

We have advanced our machine-readable covert polymer substrate development to the stage of fully manufactured banknotes with all of the key security features central banks require. This is a key achievement that could increase authentication revenues by an order of magnitude as we move up the banknote production supply chain through the combination of substrate and security in the polymer substrate once we have the opportunity to roll the product out to a large number of central banks at the rescheduled Banknote Conference in July 2021. In the meantime, we have diligently worked on establishing marketing relationships with key representation agencies around the globe.

 

Another outgrowth of the polymer supplier relationship is the development of a new type of machine -readable security thread which is based on using similar polymer substrates which are compatible with security thread manufacturing. This has been described to two potential licensing partners in the first half of this year.

 

We have also been contracted by a long standing central bank customer to develop a new technology for relatively rare and exotic counterfeits. This contract provides new opportunities to enhance our machine-readable sales opportunities for upcoming tenders with other central banks.

 

With the TruBrand authentication product having been successfully introduced in the Chinese tobacco market with over 6 million packs with our smartphone authentication in retail stores in 2019, we are back on track after a delay due to Covid-19, to undertake a large scale gravure printing trial with our existing customer in H2 which has the potential to take the sales volumes into the hundreds of millions of units in 2021. In addition, we have had a successful trial with another implementation of the technology for tobacco packaging which is being marketed to other manufacturers in China and Europe. In addition, working with our polymer partner, we have developed a new product family, a smartphone readable packaging film for use in the brand authentication market where print is not an option. This is being actively marketed to large brands such as Apple and BAT.

 

On the software security side of the Company's business, The Secure Transactions Group, formed around the various gaming technology acquisitions made in 2012, generated an Adjusted EBITDA of $156k (2019: $181k) on revenue of $693k (2019: $680k). The H1 results are in line with 2019. The group has renewed four lottery contracts during the first half of 2020, demonstrating the stickiness of our lottery customer base.

 

Strategy

The Company's strategy for increasing revenue and earnings continues to be focused on both brand authentication and a robust effort to commercialize our covert security technologies with an emphasis on polymer banknotes and technology driven existing central bank customers. The brand authentication sector offers short-term growth potential and some very large opportunities for smartphone-based technology, while the covert banknote security sector provides stable long-term, multi-decade revenues once new contracts are executed. 

Over the past four months, the Company has continued to explore possibilities of diversifying the business beyond authentication in areas where we can support this initiative with our world class core competencies in optics, engineering, physics and chemistry. We have identified certain intellectual property owned by another company, obtained academic feedback from Harvard University on this technology, and are now in the process of having the issued patents valued through an independent third party which has expertise in this area. The current candidate technology has applications to biotech assays, point of care testing and metrology. We expect to have made a decision on this specific technology by the end of H2.

 

Prospects

The Company continues to have numerous long-term and shorter-term prospects. The shorter-term opportunities are expected in the 2020-2022 period and the longer-term opportunities are expected in the 2023-2025 time frame.

The important, near-term opportunities are:

· Fulfillment of large orders for materials to a long standing central bank customer;

· Additional funding beyond the currently contracted research program with a long standing central bank customer; 

· Execution of a multi-million dollar sensor development contract with a long standing central bank customer;

· Increased number of tobacco packs sold in China with our TruBrand materials and smartphone App. Management is confident that TruBrand will reach several hundred million packs in 2021;

· Adoption of our phosphors for use by a supplier of products to a major Asian central bank;

 

 

 

· Expansion of the optical materials business with compostable K-cup customers;

· Sales of our newest patent pending phosphour product; and

· Sale of our first Aeris banknote decontamination system to a gaming casino.

 

The longer-term opportunities are:

·  A licensing and supply agreement for polymer-based technology developed with a major central bank;

· Supply of further upgraded sensor capability to a long standing central bank customer following the contracted development phase; and

· Sale of secure polymer substrate to central banks, which combines high security and a durable substrate in one product.

The combination of these prospects, both short and longer term, has positioned the company to continue its revenue growth and earnings through 2025 while continuing to develop cutting edge technologies as needed to remain the innovation leaders in the authentication industry.

 

 

 

Nabil M. Lawandy

Chief Executive Officer

September 7, 2020 

Statements of income and other comprehensive income

for the half year ended 30 June 2020

 

 

 

 

Half Year

 

Half Year

 

Full Year

 

 

to 30 Jun 2020

 

to 30 Jun 2019

 

to 31 Dec 2019

 

 

Unaudited

 

Unaudited

 

Audited

 

Note

USD '000

 

USD '000

 

USD '000

Revenues

 

 

 

 

 

 

Product

 

$ 4,436

 

$ 4,434

 

$ 8,427

Service

 

1,191

 

1,033

 

2,982

License and royalty

 

892

 

935

 

1,825

Total revenues

 

6,519

 

6,402

 

13,234

 

 

 

 

 

 

 

Cost of sales

 

2,168

 

1,969

 

3,847

 

 

 

 

 

 

 

Gross profit

 

4,351

 

4,433

 

9,387

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

Research and development

 

823

 

891

 

1,741

General and administrative

 

1,330

 

1,403

 

2,851

Sales and marketing

 

300

 

209

 

446

Total operating expenses

 

2,453

 

2,503

 

5,038

 

 

 

 

 

 

 

Operating profit

 

1,898

 

1,930

 

4,349

 

 

 

 

 

 

 

Interest and other income

 

79

 

76

 

197

Foreign currency gain (loss)

 

(1)

 

(7)

 

(11)

 

 

 

 

 

 

 

Profit before taxes

 

1,976

 

1,999

 

4,535

 

 

 

 

 

 

 

Benefit (provision) for income taxes

 

(81)

 

(11)

 

(200)

 

 

 

 

 

 

 

Net income

 

$ 1,895

 

$ 1,988

 

$ 4,335

 

 

 

 

 

 

 

Earnings per share

2

 

 

 

 

 

Basic

 

$ 0.04

 

$ 0.04

 

$ 0.09

Diluted

 

$ 0.04

 

$ 0.04

 

$ 0.09

 

 

 

 

 

 

 

Other comprehensive income (loss)

 

 

 

 

 

 

Unrealized gain (loss) on currency exchange

 

 

(9)

 

 

3

 

 

(16)

Reclassification for realized loss in net income

 

 

1

 

 

7

 

 

11

 

 

 

 

 

 

 

Total other comprehensive

income (loss)

 

 

(8)

 

 

10

 

 

(5)

 

 

 

 

 

 

 

Comprehensive income

 

$ 1,887

 

$ 1,998

 

$ 4,330

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All of the Group's operations are continuing

 

Balance sheets

as of 30 June 2020

 

 

As of

 

As of

 

As of

 

30 Jun 2020

 

30 Jun 2019

 

31 Dec 2019

 

Unaudited

 

Unaudited

 

Audited

 

USD '000

 

USD '000

 

USD '000

Current assets

 

 

 

 

 

Cash and cash equivalents

$ 10,906

 

$ 11,142

 

$ 14,250

Trade and other receivables

676

 

2,011

 

1,497

Unbilled and other receivables

929

 

-

 

295

Inventory

2,840

 

3,011

 

3,081

Prepaid expenses

234

 

229

 

189

Total current assets

15,585

 

16,393

 

19,312

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant and equipment, net

1,795

 

1,651

 

1,684

Operating lease right of use assets, net

1,313

 

1,233

 

1,104

Intangible assets, net

6,228

 

6,490

 

6,347

Restricted cash and investments

1,344

 

1,099

 

1,344

Deferred tax assets

1,400

 

1,400

 

1,400

Other assets

130

 

151

 

138

Total non-current assets

12,210

 

12,024

 

12,017

 

 

 

 

 

 

Total assets

$ 27,795

 

$ 28,417

 

$ 31,329

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

$ 356

 

$ 329

 

$ 357

Accrued expenses and other liabilities

583

 

701

 

636

Operating lease liabilities, short term

258

 

242

 

191

Taxes payable

278

 

3

 

203

Deferred revenue

719

 

887

 

1,219

Total current liabilities

2,194

 

2,162

 

2,606

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

Operating lease liabilities, long term

1,094

 

1,017

 

945

Deferred revenue

592

 

498

 

667

Total non-current liabilities

1,686

 

1,515

 

1,612

 

 

 

 

 

 

Total liabilities

3,880

 

3,677

 

4,218

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

Common stock

459

 

459

 

459

Additional paid in capital - common stock

55,537

 

55,465

 

55,505

Accumulated other comprehensive loss

(127)

 

(103)

 

(119)

Accumulated deficit

(30,960)

 

(31,079)

 

(28,732)

Less: Common stock held in treasury

(994)

 

(2)

 

(2)

Total stockholders' equity

23,915

 

24,740

 

27,111

 

 

 

 

 

 

 Total liabilities and stockholders' equity

$ 27,795

 

$ 28,417

 

$ 31,329

 

 

 

Statements of cash flows

for the half year ended 30 June 2020

 

 

 

Half Year

 

Half Year

 

Full Year

 

to 30 Jun 2020

 

to 30 Jun 2019

 

to 31 Dec 2019

 

Unaudited

 

Unaudited

 

Audited

 

USD '000

 

USD '000

 

USD '000

Cash flows from operating activities

 

 

 

 

 

Net income

$ 1,895

 

$ 1,988

 

$ 4,335

Adjustments to reconcile net income to net cash provided by operating activities

 

 

 

 

 

Depreciation and amortization

515

 

484

 

1,037

Stock based compensation expense

29

 

47

 

87

Lease amortization expense

131

 

126

 

256

Allowance for doubtful accounts

-

 

-

 

(1)

Changes in operating assets and liabilities

 

 

 

 

 

Accounts and other receivables

821

 

(795)

 

(420)

Unbilled and other receivables

(635)

 

-

 

(156)

Inventory

241

 

258

 

189

Prepaid expenses

(45)

 

(87)

 

(47)

Accounts payable

(1)

 

60

 

88

Operating leases

(126)

 

(100)

 

(223)

Accrued expenses and other liabilities

25

 

(127)

 

7

Deferred revenue

(567)

 

139

 

637

Net cash provided by operating activities

2,283

 

1,993

 

5,789

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

Restricted cash and investments

-

 

-

 

(245)

Payment of patent and trademark costs

(171)

 

(67)

 

(249)

Purchases of property, plant and equipment

(329)

 

(273)

 

(522)

Net cash used in investing activities

(500)

 

(340)

 

(1,016)

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

Dividends paid

(4,123)

 

(3,213)

 

(3,213)

Acquisition of treasury stock

(992)

 

(2)

 

(2)

Proceeds from exercise of stock options

3

 

32

 

32

Net cash used in financing activities

(5,112)

 

(3,183)

 

(3,183)

 

 

 

 

 

 

Effect of exchange rate on cash and cash equivalents

 

(15)

 

 

10

 

 

(2)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

(3,344)

 

 

(1,520)

 

 

1,588

Cash and cash equivalents, beginning of period

 

14,250

 

 

12,662

 

 

12,662

Cash and cash equivalents, end of period

$ 10,906

 

$ 11,142

 

$ 14,250

 

 

 

Notes to financial information

 

1. Basis of preparation

 

This report was approved by the Directors on 4 September 2020.

 

This financial information has been prepared using the recognition and measurement principles of US Generally Accepted Accounting Principles. The Group has not elected to apply IAS 34 Interim Financial Reporting.

 

The principal accounting policies used in preparing the interim results are those the Company expects to apply in its financial statements for the year ending 31 December 2020 and are unchanged from those disclosed in the Company's Annual Report for the year ended 31 December 2019.

 

The results for the half year are unaudited. The financial information for the year ended 31 December 2019 does not constitute the full statutory accounts for that period. The Annual Report and financial statements for the year ended 31 December 2019 have been filed with the Registrar of Companies. The Independent Auditors' Report on the financial statements for the year ended 31 December 2019 was unmodified and did not draw attention to any matters by way of emphasis.

 

2. Earnings per share

 

The calculation of basic earnings per share is based on the net income divided by the weighted average number of common shares outstanding. Diluted earnings per share is calculated by considering the dilutive impact of common stock equivalents under the treasury stock method as if they were converted into common stock as of the beginning of the period or as of the date of grant, if later. The following table shows the calculation of basic and diluted earnings per common share.

 

 

Half Year

 

Half Year

 

Full Year

 

to 30 Jun 2020

 

to 30 Jun 2019

 

to 31 Dec 2019

Numerator:

 

 

 

 

 

Net income

$ 1,895,000

 

$ 1,988,000

 

$ 4,335,000

 

 

 

 

 

 

Denominator:

 

 

 

 

 

Weighted average common shares

45,820,928

 

45,839,118

 

45,868,615

Effect of dilutive securities:

 

 

 

 

 

Stock Options

2,747,538

 

2,633,209

 

2,701,377

Diluted weighted average common shares

48,568,466

 

48,472,327

 

48,569,992

 

 

 

 

 

 

Earnings per common share:

 

 

 

 

 

Basic:

$ 0.04

 

$ 0.04

 

$ 0.09

Diluted:

$ 0.04

 

$ 0.04

 

$ 0.09

 

 

3. Copies of this statement are available to the public on the Company's website at http://www.spsy.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR LFMTTMTMMTAM
Date   Source Headline
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options
6th Dec 20217:00 amRNSNew K-cup Orders in Q4 Exceed Expectations
2nd Nov 20213:37 pmRNSExercise of Options
25th Oct 20214:18 pmRNSRemoval of Regulation S restrictions
11th Oct 20217:00 amRNSLarge Central Bank Order
13th Sep 202110:27 amRNSHolding(s) in Company
25th Aug 202111:23 amRNSRemoval of Regulation S restrictions
21st Jul 20217:00 amRNSBanknote cleaning system also deactivates Covid-19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.